Keywords
Nervous System Diseases
Colombia
Prevalence
Migraine
Epilepsy
Alzheimer Disease
Neurology
How to Cite
Abstract
Introduction: With the demographic and epidemiological transition, the prevalence of neurological pathologies is expected to increase. In particular, Colombia does not have updated indicators regarding the frequency of these diseases. Objective: To determine the prevalence of ten relevant neurological pathologies (migraine, epilepsy, Alzheimer›s disease, ischemic and hemorrhagic stroke, Parkinson›s disease, multiple sclerosis, myasthenia gravis, meningitis, Guillain-Barré syndrome and motor neuron disease) in patients aged ≥15 years between 2015-2017. Materials and methods: Cross-sectional study of administrative sources, based on the Individual Service Provision Registries (RIPS) consolidated by the Ministry of Health. The available socio- demographic characteristics (sex, age group, health regime, origin, etc.) were analyzed, and the obtained prevalences were adjusted according to the distributions of the world and national population. Results: For 2017, the prevalences adjusted to the world age distribution, per 100,000 inhabitants, were: migraine 2170 (95%CI 2164-2176); epilepsy 586 (95%CI 583-589); Alzheimer›s disease 387 (95% CI 384-389); stroke 263 (95%CI 260-265), specifically, ischemic 136 (95%CI 134-137) and hemorrhagic (95% CI 95-98); Parkinson’s disease 91 (95%CI 90-93), multiple sclerosis 19 (95%CI 18-19); myasthenia gravis 11 (95%CI 11-11); meningitis 10 (95%CI 9-10); Guillain-Barré syndrome 9 (95%CI 8-9); and motor neuron disease 6 (95%CI 5-6). The 2015-2017 median variation was 19.38%. Conclusion: The most prevalent pathologies nationwide, in order of frequency, were migraine, epilepsy, and Alzheimer›s disease.
References
Pradilla G, Vesga B, León F. Estudio neuroepidemiológico nacional en Colombia (EPINEURO). Rev Panam Salud Publica 2003;14(2): 104-111.
Takeuchi Y, Guevara J. Prevalencia de las enfermedades neurológicas en el Valle del Cauca. Estudio neuroepidemiológico nacional (EPINEURO). Colomb Med 1999; 30: 74-81.
Pradilla G, Vesga B, Bautista L. Neuroepidemiología en Piedecuesta, población semiurbana de Santander. Acta Med Colomb. 2000; 25: 286.
Pradilla G, Vesga B, León F. Estudio neuroepidemiológico en Aratoca, un área rural del oriente colombiano. Rev Med Chile 2002;130(2): 191-199. doi: 10.4067/S0034-98872002000200009
Pradilla G, Vesga B, León F, Bautista L, Nuñez L, Vesga E, et al. Neuroepidemiología en el oriente colombiano. Rev Neurol 2002; 34(11): 385-395. doi: 10.33588/rn.3411.2001486
Pradilla G, Vesga B, Bautista L. Neuroepidemiología en Piedecuesta, población semiurbana de Santander. Acta Med Colomb 2000; 25: 286.
Institute for Health Metrics and Evaluation. Global Burden of Disease: comparing tool. U Washington, 2015; http://vizhub.healthdata.org/gbd-compare
GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18(5): 459-480. doi: 10.1016/S1474-4422(18)30499-X
McWilliam M, Al Khalili Y. Idiopathic generalized epilepsy. Treasure Island: StatPearls Publishing; 2020.
Grupo ASIS. Análisis de situación de salud según regiones Colombia, 2013. Bogotá: Ministerio de Salud; 2014.
Gutiérrez V. Familia y cultura en Colombia: tipologías, funciones y dinámica de la familia. Ed. Universidad de Antioquia; 2000.
Sandoval M, Moreno C. Virginia Gutiérrez de Pineda: aportes al desarrollo del pensamiento social, del conocimiento de la familia y la formación de nación en Colombia. Antropol Sociol 2008; 10: 107-154.
United Nations. World population prospects [Internet]. UN Population Division, 2019; Available from: https://population.un.org/wpp/Download/Standard/CSV
Departamento Administrativo Nacional de Estadística. Proyecciones nacionales y departamentales de población 2005-2020. Bogotá: DANE; 2009.
Gail M, Benichou J. Encyclopedia of epidemiologic methods. New Jersey: John Wiley & Sons; 2000.
Selvin S. Statistical analysis of epidemiologic data. Oxford: Oxford University Press; 1996.
Frome E, Checkoway H. Use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol 1985; 121(2): 309-323. doi: 10.1093/oxfordjournals.aje.a114001
World Health Organization. Headache disorders. WHO Press, 2016; https://www.who.int/news-room/fact-sheets/detail/headache-disorders
World Health Organization. Dementia: A public health priority. Geneve: World Health Organization; 2012.
Orozco J, Valderrama J, Pinilla G, Molina M, Pérez A, Ariza Y. Parkinson’s disease prevalence, age distribution and staging in Colombia. Neurol Int. 2020; 12(1): 8401. doi: 10.4081/ni.2020.8401
Díaz O. Prevalencia de los diagnósticos de salud mental en Colombia: análisis de los registros del Sistema Integral de Información de la Protección Social - SISPRO. Cuadernos Hispanoamericanos de Psicología 2016; 14(2): 65-74. doi: 10.18270/chps..v14i2.1339
Takeuchi Y, Ariza Y, Prada S. Prevalence estimates of dementia in Colombia (2005-2020): transitions and stage of disease. Alzheimers Dement 2014; 10:758. doi: 10.1016/j.jalz.2014.05.1442
GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018; 17(11): 954-976. doi: 10.1016/S1474-4422(18)30322-3976. doi: 10.1016/S1474-4422(18)30322-3
Navarro M, Marín M, Bellosta E, Santos S. Epidemiología de la migraña en España y Latinoamérica. Rev Neurol 2020; 71(3): 110-118. doi: 10.33588/rn.7103.2019266
Rueda M, Mantilla F, Solano M, Ortiz C. Prevalencia de cefalea en un servicio de urgencias en Colombia. Rev Neurol 2005; 40(4): 209-213. doi: 10.33588/rn.4004.2004124
Manzoni G, Torelli P. Epidemiology of migraine. J Headache Pain 2001; 2(S1): 11-13. doi: 10.1007/s101940170002
Morillo LE, Alarcon F, Aranaga N, Aulet S, Chapman E, Conterno L, et al. Prevalence of migraine in Latin America. Headache 2005; 45(2): 106-117. doi: 10.1111/j.1526-4610.2005.05024.x
Dodick D. Migraine. Lancet 2018;391(10127):1315– 30. doi: 10.1016/S0140-6736(18)30478-1
Charles A. Migraine. N Engl J Med 2017; 377(6): 553-561. doi: 10.1056/NEJMcp1605502
GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990– 2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18(4): 357-375. doi: 10.1016/S1474-4422(18)30454-X
Beghi E. The epidemiology of epilepsy. Neuroepidemiology 2020; 54(2): 185-191. doi: 10.1159/000503831
Gomez J, Arciniegas E, Torres J. Prevalence of epilepsy in Bogota, Colombia. Neurology 1978; 28(1): 90-94. doi: 10.1212/wnl.28.1.90
Velez A, Eslava J. Epilepsy in Colombia: epidemiologic profile and classification of epileptic seizures and syndromes. Epilepsia 2006; 47(1): 193-201. doi: 10.1111/j.1528-1167.2006.00387.x
GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18(1): 88-106. doi: 10.1016/S1474-4422(18)30403-4
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri C. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimers Dement 2013; 9(1): 63-75. doi: 10.1016/j.jalz.2012.11.007
Ferri C, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguile M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366(9503): 2112-2117. doi: 10.1016/S0140-6736(05)67889-0
Garre J. Epidemiología de la enfermedad de Alzheimer y otras demencias. Rev Neurol 2018; 66(11): 377-386. doi: 10.33588/rn.6611.2017519
Prada S, Takeuchi Y, Merchán A, Ariza Y. Actual expense associated with patients with Alzheimer’s disease in Colombia. Int Psychogeriatr 2017; 29(11): 1835-1840. doi: 10.1017/S1041610217000710
Ezejimofor M, Chen Y, Kandala N, Ezejimofor C, Ezeabasili A, Stranges S, et al. Stroke survivors in low- and middle-income countries: a meta-analysis of prevalence and secular trends. J Neurol Sci. 2016; 364: 68-76. doi: 10.1016/j.jns.2016.03.016
Marquez J, Arauz A, Góngora F, Barinagarrementeria F, Cantú C. The burden of stroke in México. Int J Stroke 2015; 10(2): 251- 252. doi: 10.1111/ijs.12189
Melcon C, Melcon M. Prevalence of stroke in an Argentine community. Neuroepidemiology 2006; 27(2): 81-88. doi: 10.1159/000094978
Aguilera M, Cardenas A, Baracaldo I, Garcia E, Ocampo M, Coral E. Ischemic stroke in young adults in Bogota, Colombia: a cross-sectional study. Neurol Sci 2020; 42(2): 639-645. doi: 10.1007/s10072-020-04584-2
Yanez N, Useche J, Bayona H, Porras A, Carrasquilla G. Analyses of mortality and prevalence of cerebrovascular disease in Colombia, South America (2014-2016): A cross-sectional and ecological study. J Stroke Cerebrovasc Dis. 2020; 29(5): 1-9. doi: 10.1016/j.jstrokecerebrovasdis.2020.104699
Observatorio Nacional de Salud. Carga de enfermedad por enfermedades crónicas no transmisibles y discapacidad en Colombia. Bogotá: Instituto Nacional de Salud; 2015.
GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018; 17(11): 939-953. doi: 10.1016/S1474-4422(18)30295-3
Correa E, Paredes V, Martínez B. Prevalence of multiple sclerosis in Latin America and its relationship with European migration. Mult Scler J Exp Transl Clin. 2016; 2: 1-10. doi: 10.1177/2055217316666407
GBD 2016 Multiple Sclerosis Collaborators. Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(3): 269-285. doi: 10.1016/S1474-4422(18)30443-5
Jiménez C, Zarco L, Castañeda C, Otálora M, Martínez A, Rosselli D. Current status of multiple sclerosis in Colombia. Value Health. 2016; 19(3): PA70. doi: 10.1016/j.jval.2016.03.226
Toro J, Sarmiento O, Díaz A, Satizábal C, Ramírez J, Montenegro A, et al. Prevalence of multiple sclerosis in Bogotá, Colombia. Neuroepidemiol. 2007; 28(1): 33-38. doi: 10.1159/000097854
Kurtzke J. A reassessment of the distribution of multiple sclerosis. Acta Neurol Scand. 1975; 51(2): 137-157. doi: 10.1111/j.1600-0404.1975.tb01365.x
Filippi M, Bar A, Piehl F, Preziosa P, Solari A, Vukusic S, et al. Multiple sclerosis. Nat Rev Dis Primers. 2018; 4(1): 43. doi: 10.1038/s41572-018-0041-4
Carr A, Cardwell C, McCarron P, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010; 10: 46. doi: 10.1186/1471-2377-10-46
Sánchez J, Uribe C, Franco A, Jiménez M, Arcos- Burgos O, Palacio L. Prevalencia de miastenia gravis en Antioquia, Colombia. Rev Neurol. 2002; 34(11): 1010-1012. doi: 10.33588/rn.3411.2001523
Mateus H, Pérez A, Mesa M, Escobar G, Gálvez J, Montaño J, et al. A first description of the Colombian national registry for rare diseases. BMC Res Notes. 2017; 10(1): 514. doi: 10.1186/s13104-017-2840-1
Machado J, Calvo L, Gaviria A, Mejía C. Prescription profile of pyridostigmine use in a population of patients with myasthenia gravis. Muscle Nerve 2017;56(6):1041-6. doi: 10.1002/mus.25625
Castañeda C, Alvis N, de la Hoz F. The impact of pneumococcal disease on adults living in Bogota, Colombia, 2008. Rev Salud Publica 2010;12(1):38– 50. doi: 10.1590/s0124-00642010000100004
Rosselli D, Rueda J. Burden of pneumococcal infection in adults in Colombia. J Infect Public Health. 2012; 5(5): 354-359. doi: 10.1016/j.jiph.2012.04.003
Vélez A, Medina N, Besada S, Mojica J. Epidemiología de la enfermedad por meningococo en Colombia. Infectio. 2016; doi: 10.22354/in.v21i1.637
Acevedo W, Buitrago D, Atehortua M, Páez M, Jiménez M, Lagos G, et al. Influence of socio-economic inequality measured by the Gini coefficient on meningitis incidence caused by Mycobacterium tuberculosis and Haemophilus influenzae in Colombia, 2008-2011. Infez Med. 2017; 25(1): 8-12.
Firacative C, Lizarazo J, Illnait M, Castañeda E. Latin American Cryptococcal Study Group. The status of cryptococcosis in Latin America. Mem Inst Oswaldo Cruz 2018; 113(7): e170554. doi: 10.1590/0074-02760170554
McGrogan A, Madle G, Seaman H, de Vries C. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiol.2009; 32(2): 150-163. doi: 10.1159/000184748
Leonhard S, Bresani C, Lyra J, Cunha S, Jacobs B, Brito M, et al. Guillain-Barré syndrome related to Zika virus infection: a systematic review and meta-analysis of the clinical and electrophysiological phenotype. PLoS Negl Trop Dis. 2020; 14(4): e0008264. doi: 10.1371/journal.pntd.0008264
Parra B, Lizarazo J, Jiménez J, Zea A, González G, Vargas J, et al. Guillain-Barré syndrome associated with Zika virus infection in Colombia. N Engl J Med. 2016; 375(16): 1513-1523. doi: 10.1056/NEJMoa1605564
Betancur L, Bedoya A, Arias J, Cardona A. Relación entre síndrome de Guillain-Barré e infección por el virus Zika: Revisión sistemática de la literatura. Arch Medicina. 2016; 12(3): 18. doi: 10.3823/1317
Kristensen O, Melgaard B. Motor neuron disease: prognosis and epidemiology. Acta Neurol Scand. 2009; 56(4): 299-308. doi: 10.1111/j.1600-0404.1977.tb01437.x
Vadillo A, Berciano J. Enfermedades de las neuronas motoras (II). Esclerosis lateral amiotrófica. Medicine 2003; 8(98): 5293-5307. doi: 10.1016/S0304-5412(03)70984-6
Juergens S, Kurland L, Okazaki H, Mulder D. Amyotrophic lateral sclerosis in Rochester, Minnesota, 1925-1977. Neurology. 1980; 30(5): 463-470. doi: 10.1212/wnl.30.5.463
Kurland L. Descriptive epidemiology of selected neurologic and myopathic disorders with particular reference to a survey in Rochester, Minnesota. J Chronic Dis. 1958; 8(4): 378-418. doi: 10.1016/0021-9681(58)90002-x
Zapata C, Franco E, Aguirre D, de Carvalho M, Solano J. Prevalence, incidence, and clinical-epidemiological characterization of amyotrophic lateral sclerosis in Antioquia: Colombia. Neuroepidemiology 2020; 54(3): 251-257. doi: 10.1159/000504549
Argyriou A, Polychronopoulos P, Papapetropoulos S, Ellul J, Andriopoulos I, Katsoulas G, et al. Clinical and epidemiological features of motor neuron disease in south-western Greece. Acta Neurol Scand. 2005; 111(2): 108-113. doi: 10.1111/j.1600-0404.2004.00362.x
Muñoz J. Encuesta colombiana de neurología. Acta Neurol Colomb. 2012; 28: 180-186.
Restrepo D, Ortíz L. Aproximaciones a la estimación de la oferta y la demanda de médicos especialistas en Colombia, 2015-2030. Bogotá: Ministerio de Salud; 2017.
Sarmiento P. La oferta de prestadores de consulta neurológica en Colombia: estadísticas del Registro Especial de Prestadores de Servicios de Salud. Acta Neurol Colomb. 2019; 35(2): 116-117. doi: 10.22379/24224022242
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Gabriel David Pinilla-Monsalve, Jean Paul Vergara-Aguilar, Belen Machado-Noguera, Julián Gutiérrez-Baquero, Zaida Cabezas-Vargas, Juliana Bejarano-Hernández